Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Acute lymphocytic leukaemia recurrent+5

Recruiting

InvestigationalNo placebo

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:AZD3632

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Recruiting

Registered drugNo placebo

Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

Registered drugNo placebo

Greece

Participants:0–17 years · 18–64 years
Substances:Cyclophosphamide

Contact Research Centre

Acute lymphocytic leukaemia recurrent+1

Recruiting

InvestigationalNo placebo

Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector

Contact Research Centre

Acute lymphocytic leukaemia recurrent+5

Recruiting

InvestigationalNo placebo

Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Mb-Cart20.1

Contact Research Centre

Acute lymphocytic leukaemia recurrent+1

Not yet recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Acute lymphocytic leukaemia recurrent+6

Not yet recruiting

InvestigationalNo placebo

A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:MB-HUCART19.1

Contact Research Centre

Acute lymphocytic leukaemia recurrent+2

Not yet recruiting

InvestigationalNo placebo

A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

InvestigationalNo placebo

France

Participants:0–17 years
Substances:Blinatumomab

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Not recruiting

Registered drugNo placebo

Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Tisagenlecleucel

Contact Research Centre

Acute lymphocytic leukaemia recurrent

Not recruiting

Registered drugNo placebo

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Inotuzumab Ozogamicin

Contact Research Centre

Find therapies in clinical trials near you

9 trials match your criteria

Acute lymphocytic leukaemia recurrent+5

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

Acute lymphocytic leukaemia recurrent

Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

Acute lymphocytic leukaemia recurrent+1

Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

Acute lymphocytic leukaemia recurrent+5

Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

Acute lymphocytic leukaemia recurrent+1

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Acute lymphocytic leukaemia recurrent+6

A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

Acute lymphocytic leukaemia recurrent+2

A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

Acute lymphocytic leukaemia recurrent

Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

Acute lymphocytic leukaemia recurrent

Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.